Results 251 to 260 of about 1,251,348 (401)

Learning From Those Who Have Lived: A Scoping Review Exploring the Involvement of Lived Experience Co‐Design in Eating Disorder Research Methodologies

open access: yesInternational Journal of Eating Disorders, EarlyView.
ABSTRACT Objective There is a growing demand in health research and policy to meaningfully involve people with lived experience in co‐creating research and treatment services, especially in eating disorders. Despite decades of research into risk, origin, onset, progression, and intervention, significant knowledge gaps remain. The aim of this review was
Jane Miskovic‐Wheatley   +6 more
wiley   +1 more source

The Imperative of New and Shiny Clothes: A Discussion on Novelty and Its Effects in Water Governance Research

open access: yesEnvironmental Policy and Governance, EarlyView.
ABSTRACT Novelty is a requirement demanded from scholars by reviewers holding the keys to publication as well as by funding bodies allocating project funds and thus sometimes enabling the possibility of an academic career. In fields such as water governance research, at the intersection of research and practice, an additional pressure comes from ...
María Mancilla García, Örjan Bodin
wiley   +1 more source

The role of cardiac acoustic biomarkers in monitoring patients with heart failure: A systematic literature review

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 980-997, April 2025.
Abstract Heart failure (HF) creates a considerable clinical, humanistic and economic burden on patients and caregivers as well as on healthcare systems. To attenuate the significant burden of HF, there is a need for enhanced management of patients with HF.
Javed Butler   +8 more
wiley   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy